Management of Concurrent BK Virus and E. coli UTI in Renal Transplant Patients

Diagnosis and Monitoring

Obtain quantitative BK virus plasma NAT immediately to determine the severity of BK viremia and guide immunosuppression reduction, according to the Kidney International guidelines 1, 2
Check serum creatinine to assess for any unexplained rise that might indicate BK nephropathy, as recommended by Kidney International 1
Repeat quantitative BK virus plasma NAT weekly initially after immunosuppression reduction to assess treatment response, as suggested by Praxis Medical Insights 3, 2
Continue monitoring every 1-2 weeks until viral load decreases or stabilizes, according to Kidney International 1

Reduce immunosuppressive medications if BK virus plasma NAT is persistently greater than 10,000 copies/ml, as recommended by Kidney International 1, 4, 5, 6
Monitor graft function closely (serum creatinine at least weekly initially) during immunosuppression reduction to detect early rejection, as suggested by Kidney International and Praxis Medical Insights 1, 7, 3
Use culture-guided therapy with appropriate dosing for renal function for complicated UTI with systemic symptoms, according to Praxis Medical Insights 3
Consider hospitalization if sepsis is suspected, as recommended by Kidney International 6

Check serum creatinine, BUN, and electrolytes at least twice weekly during initial immunosuppression reduction, as suggested by Praxis Medical Insights 3
Perform urinalysis regularly to monitor for hematuria (which could indicate BK nephropathy progression), according to Kidney International 6
Repeat urine culture 1-2 weeks after completing antibiotics to confirm clearance, as recommended by Kidney International 6
Monitor for recurrent UTI symptoms, as suggested by Praxis Medical Insights 3

Consider low-dose cidofovir (1 mg/kg IV weekly without probenecid) only if BK nephropathy is biopsy-proven and progressive despite maximal immunosuppression reduction, as suggested by Praxis Medical Insights 3
Alternative: Foscarnet can be used if cidofovir is contraindicated, but requires close monitoring for electrolyte abnormalities (hypocalcemia, hypophosphatemia, hypomagnesemia), according to Praxis Medical Insights 3

Do not delay immunosuppression reduction while waiting for biopsy results if BK plasma viral load is >10,000 copies/ml, as recommended by Kidney International and Praxis Medical Insights 1, 3
Do not over-reduce immunosuppression precipitously—gradual reduction with close monitoring prevents acute rejection, according to Kidney International and Praxis Medical Insights 1, 3
Do not rely solely on urine BK testing—plasma viral load is more specific for nephropathy risk, as suggested by Praxis Medical Insights 2